A Metabolic Labeling Strategy for Relative Protein Quantification in Clostridioides difficile

Area of Science:

• Microbiology
• Proteomics
• Biochemistry

Background:

• Clostridioides difficile is a major cause of hospital-acquired infections.
• Accurate proteome analysis is crucial for identifying new drug targets.
• Previous quantitative proteomic studies for C. difficile were limited by labeling challenges.

Purpose of the Study:

• To develop and validate a metabolic labeling (ML) strategy for quantitative proteome analysis of Clostridioides difficile.
• To compare the performance of ML with label-free quantification methods.
• To assess the sensitivity and accuracy of ML for detecting protein abundance changes.

Main Methods:

• Established a 15N-labeled media cultivation procedure for C. difficile strain 630Δerm with >97% incorporation.
• Applied ML to quantify the cytosolic subproteome under different growth conditions.
• Compared ML data with label-free quantification approaches (NSAF and LFQ).

Main Results:

• Achieved high 15N incorporation rates, enabling ML implementation.
• Identified a comparable number of proteins across ML and label-free methods.
• ML demonstrated higher sensitivity in detecting proteins with small fold-change differences and provided more distinct clustering of conditions.

Conclusions:

• The developed ML approach is accurate, reproducible, and more sensitive than label-free methods for C. difficile quantitative proteomics.
• This method facilitates the identification of subtle protein abundance changes, crucial for understanding C. difficile pathogenesis.
• ML provides a powerful tool for discovering novel therapeutic targets against C. difficile infections.